Trial Profile
Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis: A Double-blind, Randomized Placebo-controlled Pilot Study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Ursodeoxycholic acid
- Indications Colorectal cancer; Ulcerative colitis
- Focus Pharmacogenomic; Therapeutic Use
- 19 Apr 2010 New trial record